Literature DB >> 11878710

Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans.

J Oksi1, H Marttila, H Soini, H Aho, J Uksila, M K Viljanen.   

Abstract

The diagnosis of erythema migrans (EM) is not always easy, and reports of culture- or PCR-confirmed diagnosis as well as reports of EM with simultaneous disseminated disease are few. Characteristics and incidence of EM in addition to frequency of early dissemination of B. burgdorferi were studied in the archipelago of South-Western Finland prospectively using questionnaires, skin biopsies and blood samples. Clinical EM was recognized in 82 patients (incidence 148/100,000 inhabitants/year). Of skin biopsy samples, 35.5% were positive by PCR (the majority B. garinii), and 21.5% by cultivation (all B. garinii). Of blood samples, 3.8% were positive by PCR, and 7.7% by cultivation. Of the patients, 30.9% were seropositive at the first visit, and 52.9% 3 weeks later. Of the patients with laboratory confirmed diagnosis, the EM lesion was ring-like in 31.8% and homogeneous in 65.9%. Dissemination of B. burgdorferi, based on culture or PCR positivity of blood samples, was detected in 11.0% of the patients. The frequency of generalized symptoms was nearly the same in patients with as in those without dissemination (22.2% vs 27.4%). Only 21.4% of the patients with culture-positive EM recalled a previous tick bite at the site of the EM lesion. We conclude that EM lesions are more often homogeneous than ring-like. B. burgdorferi may disseminate early without generalized symptoms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11878710     DOI: 10.1034/j.1600-0463.2001.d01-178.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

Review 1.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

2.  Comparison of Borrelia burgdorferi sensu lato strains isolated from specimens obtained simultaneously from two different sites of infection in individual patients.

Authors:  Eva Ruzic-Sabljic; Maja Arnez; Mateja Logar; Vera Maraspin; Stanka Lotric-Furlan; Joze Cimperman; Franc Strle
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 3.  Hematogenous dissemination in early Lyme disease.

Authors:  Gary P Wormser
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

4.  Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.

Authors:  J Oksi; J Nikoskelainen; H Hiekkanen; A Lauhio; M Peltomaa; A Pitkäranta; D Nyman; H Granlund; S-A Carlsson; I Seppälä; V Valtonen; M Viljanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

5.  Comparison of detection of Borrelia burgdorferi DNA and anti-Borrelia burgdorferi antibodies in patients with erythema migrans in north-eastern Poland.

Authors:  Anna Moniuszko; Justyna Dunaj; Joanna Zajkowska; Piotr Czupryna; Renata Świerzbińska; Katarzyna Guziejko; Piotr Aleksiejczuk; Gerald Barry; Maciej Kondrusik; Sławomir Pancewicz
Journal:  Postepy Dermatol Alergol       Date:  2015-02-01       Impact factor: 1.837

6.  Rapid clearance of Borrelia burgdorferi from the blood circulation.

Authors:  Liucun Liang; Jinyong Wang; Lucas Schorter; Thu Phong Nguyen Trong; Shari Fell; Sebastian Ulrich; Reinhard K Straubinger
Journal:  Parasit Vectors       Date:  2020-04-21       Impact factor: 3.876

7.  Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study.

Authors:  Kesia Backman; Barbro H Skogman
Journal:  BMC Pediatr       Date:  2018-06-11       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.